Research study Program year 2024 Source: CMS Open Payments

Phase I Abemaciclib + BI 836845

Research payments

$3,175,927

71 payments

Through program year 2024, $3,175,927 in research payments was reported against Phase I Abemaciclib + BI 836845, across 71 payments.

Paid by (largest first): Boehringer Ingelheim Pharma GmbH & Co.KG; Boehringer Ingelheim Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$149,611	3
2021	Research	$1,243,572	38
2020	Research	$1,782,745	30

Breakdown

Who paid Research payments · program years 2020–2024

Boehringer Ingelheim Pharma GmbH & Co.KG $3,026,317 68 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $149,611 3 payments

Who received the money Research payments · program years 2020–2024

Comprehensive Cancer Centers Of Nevada Organisation paid for research $1,238,531 14 payments
Masonic Cancer Center University Of Minnesota Organisation paid for research $387,829 14 payments
University Of North Carolina Hosp. Teaching hospital · NC $348,183 6 payments
The University Of North Carolina At Chapel Hill Organisation paid for research $333,921 8 payments
University Of Minnesota Masonic Cancer Center Organisation paid for research $270,283 6 payments
Yale University School Of Medicine Organisation paid for research $231,718 3 payments
Ucla Medcl Ctr Organisation paid for research $81,644 3 payments
Sarcoma Oncology Center Organisation paid for research $79,510 5 payments
University Of Miami Hospital Teaching hospital · FL $78,119 3 payments
Allison Curtis Kingsley Meoz Michael Sanchez Prof Corp Organisation paid for research $45,486 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.